Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P de Boer

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Oral Oncology|January 9, 2019
From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approachR T Karsten, M M Stuiver, L van der Molen, et al.
Oral Oncology|December 12, 2017
Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavityJoris B W Elbers, Abrahim Al-Mamgani, Danique Paping, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 6, 2024
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancerA V M Burger, C W Duinkerken, K E van Sluis, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 12, 2018
Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and NeckJoris B W Elbers, Abrahim Al-Mamgani, Michiel W M van den Brekel, et al.
EJNMMI Research|March 12, 2021
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodineV Mohan, N M Bruin, M E T Tesselaar, et al.
Cell Death and Differentiation|August 19, 2007
Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protectionD Y H Hallaert, R Spijker, M Jak, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II studyC M L Driessen, J P de Boer, H Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literatureA V de Jonge, T J A Roosma, I Houtenbos, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oral Oncology|January 9, 2019
From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approachR T Karsten, M M Stuiver, L van der Molen, et al.
Oral Oncology|December 12, 2017
Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavityJoris B W Elbers, Abrahim Al-Mamgani, Danique Paping, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|September 6, 2024
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancerA V M Burger, C W Duinkerken, K E van Sluis, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 12, 2018
Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and NeckJoris B W Elbers, Abrahim Al-Mamgani, Michiel W M van den Brekel, et al.
EJNMMI Research|March 12, 2021
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodineV Mohan, N M Bruin, M E T Tesselaar, et al.
Cell Death and Differentiation|August 19, 2007
Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protectionD Y H Hallaert, R Spijker, M Jak, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II studyC M L Driessen, J P de Boer, H Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literatureA V de Jonge, T J A Roosma, I Houtenbos, et al.
Pageof 4